These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

844 related items for PubMed ID: 18596379

  • 1. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H, Kawaguchi T, Wada T, Takahashi Y, Higashi T, Yamazaki S, Fukuhara S, Akiba T, Akizawa T, Asano Y, Kurokawa K, Saito A, J-DOPPS Research Group.
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [Abstract] [Full Text] [Related]

  • 2. Dialyzer membrane permeability and survival in hemodialysis patients.
    Chauveau P, Nguyen H, Combe C, Chêne G, Azar R, Cano N, Canaud B, Fouque D, Laville M, Leverve X, Roth H, Aparicio M, French Study Group for Nutrition in Dialysis.
    Am J Kidney Dis; 2005 Mar; 45(3):565-71. PubMed ID: 15754279
    [Abstract] [Full Text] [Related]

  • 3. Effect of membrane flux and dialyzer biocompatibility on survival in end-stage diabetic nephropathy.
    Götz AK, Böger CA, Popal M, Banas B, Krämer BK.
    Nephron Clin Pract; 2008 Mar; 109(3):c154-60. PubMed ID: 18663328
    [Abstract] [Full Text] [Related]

  • 4. The effect of high-flux hemodialysis on renal anemia.
    Ayli D, Ayli M, Azak A, Yüksel C, Kosmaz GP, Atilgan G, Dede F, Abayli E, Camlibel M.
    J Nephrol; 2004 Mar; 17(5):701-6. PubMed ID: 15593038
    [Abstract] [Full Text] [Related]

  • 5. Determinants of prescribed dialysis dose and survival in a cohort of chronic hemodialysis patients.
    Iseki K, Tozawa M, Takishita S.
    Clin Exp Nephrol; 2003 Sep; 7(3):231-7. PubMed ID: 14586720
    [Abstract] [Full Text] [Related]

  • 6. Biocompatible dialysis membranes and acute renal failure: a study in post-operative acute tubular necrosis in cadaveric renal transplant recipients.
    Valeri A, Radhakrishnan J, Ryan R, Powell D.
    Clin Nephrol; 1996 Dec; 46(6):402-9. PubMed ID: 8982557
    [Abstract] [Full Text] [Related]

  • 7. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane.
    Chanard J, Lavaud S, Maheut H, Kazes I, Vitry F, Rieu P.
    Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457
    [Abstract] [Full Text] [Related]

  • 8. Reuse-associated mortality in incident hemodialysis patients in the United States, 2000 to 2001.
    Fan Q, Liu J, Ebben JP, Collins AJ.
    Am J Kidney Dis; 2005 Oct; 46(4):661-8. PubMed ID: 16183421
    [Abstract] [Full Text] [Related]

  • 9. Association between erythropoietin requirements and antihypertensive agents.
    Yano S, Suzuki K, Iwamoto M, Urushidani Y, Yokogi H, Kusakari M, Aoki A, Sumi M, Kitamura K, Sanematsu H, Gohbara M, Imamura S, Sugimoto T.
    Nephron Clin Pract; 2008 Oct; 109(1):c33-9. PubMed ID: 18506108
    [Abstract] [Full Text] [Related]

  • 10. Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis.
    Krane V, Krieter DH, Olschewski M, März W, Mann JF, Ritz E, Wanner C.
    Am J Kidney Dis; 2007 Feb; 49(2):267-75. PubMed ID: 17261429
    [Abstract] [Full Text] [Related]

  • 11. Independent and joint associations of nutritional status indicators with mortality risk among chronic hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Lopes AA, Bragg-Gresham JL, Elder SJ, Ginsberg N, Goodkin DA, Pifer T, Lameire N, Marshall MR, Asano Y, Akizawa T, Pisoni RL, Young EW, Port FK.
    J Ren Nutr; 2010 Jul; 20(4):224-34. PubMed ID: 20060319
    [Abstract] [Full Text] [Related]

  • 12. Characteristics and treatment of patients not reusing dialyzers in reuse units.
    Okechukwu CN, Orzol SM, Held PJ, Pereira BJ, Agodoa LY, Wolfe RA, Port FK.
    Am J Kidney Dis; 2000 Nov; 36(5):991-9. PubMed ID: 11054356
    [Abstract] [Full Text] [Related]

  • 13. Effect of anemia and hyperhomocysteinemia on mortality of patients on hemodialysis.
    Anees M, Mumtaz A, Ibrahim M, Shaheen SM, Asghar A.
    Iran J Kidney Dis; 2010 Jan; 4(1):60-5. PubMed ID: 20081306
    [Abstract] [Full Text] [Related]

  • 14. Epoetin requirement does not depend on dialysis dose when Kt/N > 1.33 in patients on regular dialysis treatment with cellulosic membranes and adequate iron stores.
    Movilli E, Cancarini GC, Vizzardi V, Camerini C, Brunori G, Cassamali S, Maiorca R.
    J Nephrol; 2003 Jan; 16(4):546-51. PubMed ID: 14696757
    [Abstract] [Full Text] [Related]

  • 15. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK.
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [Abstract] [Full Text] [Related]

  • 16. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study.
    Port FK, Wolfe RA, Hulbert-Shearon TE, Daugirdas JT, Agodoa LY, Jones C, Orzol SM, Held PJ.
    Am J Kidney Dis; 2001 Feb; 37(2):276-86. PubMed ID: 11157367
    [Abstract] [Full Text] [Related]

  • 17. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K, Krouzzecký A, Polanská K, Mares J, Tomsů M, Bowry SK, Vienken J.
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [Abstract] [Full Text] [Related]

  • 18. Association between body mass and mortality in maintenance hemodialysis patients.
    Yen TH, Lin JL, Lin-Tan DT, Hsu CW.
    Ther Apher Dial; 2010 Aug 01; 14(4):400-8. PubMed ID: 20649761
    [Abstract] [Full Text] [Related]

  • 19. The current state of chronic dialysis treatment in Japan (as of December 31, 2000).
    Ther Apher Dial; 2003 Feb 01; 7(1):3-35. PubMed ID: 12921111
    [Abstract] [Full Text] [Related]

  • 20. Anemia management and treatment response in patients on hemodialysis: the MAR study.
    Portolés J, López-Gómez JM, Aljama P.
    J Nephrol; 2006 Feb 01; 19(3):352-60. PubMed ID: 16874697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.